Gardasil Appears More Cost-Effective Than Cervarix

A new study suggests that Merck’s cervical cancer vaccine, Gardasil, was more cost effective than the popularly used Cervarix

A new study published in the British Medical Journal suggests that Merck’s cervical cancer vaccine, Gardasil, was more cost effective than the popularly used Cervarix manufactured by GlaxoSmithKline's (GSK).

The Department of Health in Britain had picked Cervarix as the cheaper option to be made available through NHS. According to the list price posted by NHS, Cervarix costs the service around £80.50 per dose compared to Gardasil’s price tag of £88.50 per dose.

Cervical Cancer - Types, Causes, Symptoms, Diagnosis, Treatment, Complications & Prevention
Cancer cervix refers to cancerous growth in the cervix and usually occurs in the transition called squamo-columnar junction.

However the new study by Health Protection Agency (HPA) suggests that it is Gardasil that provides a more cost effective service compared to Cervarix.

The study said that while both the vaccines were effective against HPV types 16 and 18, Gardasil also provided protection against types 6 and 11. The researchers said that this made Gardasil a better prospect compared to Cervarix.

Source-Medindia

Pap smear and Cervical Cancer Screening
Pap smear is the most common test used in screening cervical cancer caused by an infection with human papilloma virus. Pap smear should be repeated every 1 to 3 years till the age of 65 years.

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.